BRN (ASX) 2020 BRN Discussion

Originally posted by Fact Finder: ↑

Whether you are holding at the Blue Chip or Speccy end of the market if you are a long term investor the one truth is you have absolutely nothing to add to the share price of a company except when there is a capital raise and you have the opportunity to participate and take up your allocation and lock them away or when the company achieves its purpose and the share price rises and then your long term holding limits supply to the market and as a result forces up the price for anyone who finally has realised what you knew all along.

Over the last couple of weeks there have been days when the price of BRN has moved 2 to 3 cents based on volumes representing less than point five of a percent of the total shares on issue. As a long term holder you either learn to live with the fact that most of the time holders of 99% of the share capital will have no impact whatsoever on the day to day share price or move on or decide to become a trader.

At the moment the CEO has stated on a number of occasions that first quarter/early 2021 is when commercial announcements are likely to be made with the possibility of something late 2020. These sorts of announcements are what the market is looking for now so until then the price will be manipulated at the edges and as we get closer to Christmas supply will tighten in anticipation of an announcement.

The CEO and the CFO have made clear much is going on behind the scenes in particular the work being done by the CTO and team over in Perth and we have had an announcement that the CTO will on 18.11.20 present to the world at large regarding AKIDA focusing:

"on the applications BrainChip has developed on pure spiking platforms, such as Cyber-security, Odor (disease) classification, taste classification, and preventative maintenance using nothing but STDP training. He will also discuss CNN2SNN conversion, incremental learning with fixed features, and more."

This information will reinforce the belief of long term holders and act as a bridge to Christmas and early 2021 as will announcements that the masks have been produced. There is the possibility that the names of further EAP customers might be released but once again this will in my opinion be more valued by long term holders than the market generally.

It is possible that Vorago/BRN could announce that they have a hardened AKD1000 in hand ready for further testing by NASA but again I suspect this will only really be valued by existing long term holders.

I stated at the beginning of this year that 50 cents by Christmas was my best guess of where the share price would go if everything predicted by the company went to plan. I remain of this opinion and feel comfortable about this knowing that since last year when the design of AKD1000 was completed by Peter van der Made and Anil Mankar all of the company's predicted timelines have been met and much more has been achieved and announced than I expected or was led to believe would occur.

The CEO has stated 2021 is Brainchip's year and at this point I know of nothing to say this statement is incorrect.

If the announced vaccine is rolled out in 2021 then it may well be an even better year than predicted as confidence is restored across the world.

My opinion only DYOR.

Expand

Love your work FF.
I like the way you differentiate between what long term and short term holders value, so true.
U really valued snooping out *with the HC GROUPS help*
our EAP directly with NASA. That meant sooo much to me. Both the EAP and the way LDN and co didn't have a trading halt and a big fancy announcement. Gotta make you wonder why, makes me wonder why. I love it.

But what means the most to me is what you saud about LDNs 2021 timeline, its well on track, but add to that THE TOOLING!!!!
That's the kicker for me. BRN will announce TOOLING by XMAS and fickle traders wont care, but be warned - sell now at your own perril.
Sell sub $5 at your own perril.
This could be a paradigm shif it computing as we know it and will fill a gap before the dawn of quantum computers.

No.	Vol.	Price($)
14	516291	19.5¢

No.

Vol.

Price($)

516291

19.5¢

Price($)	Vol.	No.
20.0¢	1158060	31

Price($)

Vol.

No.

20.0¢

1158060

No.	Vol.	Price($)
14	516291	0.195
86	2536976	0.190
40	2085642	0.185
58	1661242	0.180
21	425405	0.175

No.

Vol.

Price($)

516291

0.195

2536976

0.190

2085642

0.185

1661242

0.180

425405

0.175

Price($)	Vol.	No.
0.200	1158060	31
0.205	1015791	23
0.210	1064366	27
0.215	566597	22
0.220	677708	22

Price($)

Vol.

No.

0.200

1158060

0.205

1015791

0.210

1064366

0.215

566597

0.220

677708

(20min delay)
Last 19.5¢		Change 0.005(2.63%)		Mkt cap ! $361.9M

Open	High	Low	Value	Volume
19.5¢	20.0¢	19.0¢	$661.1K	3.388M

2020 BRN Discussion, page-17262

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2020 BRN Discussion, page-17262

Top Stories

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News